Cancer Research Infection and Cancer: Biology, Therapeutics, and Prevention  Tumor Immunology: New Perspectives
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 59, 4194-4199, September 1, 1999]
© 1999 American Association for Cancer Research

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Zhu, W.-Y.
Right arrow Articles by Melera, P. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Zhu, W.-Y.
Right arrow Articles by Melera, P. W.
[Cancer Research 59, 4194-4199, September 1, 1999]
© 1999 American Association for Cancer Research


Advances in Brief

Metallothionein Is Overexpressed by Hamster Fibroblasts Selected for Growth in 15 pM Folinic Acid and Provides a Growth Advantage in Low Folate1

Wei-Yong Zhu and Peter W. Melera2

Department of Biochemistry and Molecular Biology [W. Z., P. W. M.] and the Greenebaum Cancer Center [P. W. M.], University of Maryland School of Medicine, Baltimore, Maryland 21201

DC-3F/FA3 (FA3) cells, selected for growth in folic acid-free medium containing dialyzed serum and 15 pM [6S] -folinic acid, and parental DC-3F cells were compared by mRNA differential display to identify genetic changes occurring during selection. One of the genes found to be overexpressed in FA3 cells was metallothionein II (MT-II). Northern blots using a full-length hamster MT-II cDNA probe that recognizes both MT-I and MT-II RNA showed that the steady-state level of MT mRNA was elevated at least 10-fold in FA3 cells and in two other selected clones, FA7 and FA14, as well. Southern blot analysis of HindIII-digested genomic DNA indicated that amplification of neither the MT-I nor MT-II gene had occurred, and measurements of MT mRNA decay rates in the presence of actinomycin D suggested that no changes in its half-life had taken place. Hence, overexpression was due to an increase in transcription from the normal gene complement. In FA3 cells, the MT mRNA expression level was found to be directly sensitive and inversely proportional to media folate concentrations, whereas in DC-3F cells it was not, suggesting that MT gene expression is differentially regulated in these two cell lines. Overexpression of MT-II in transfected DC-3F cells was unable to support growth in 15 pM folinic acid. However, when plated in 15 nM folinic acid, a growth rate similar to FA3 cells was observed, whereas sham-transfected controls and double transfectants expressing antisense MT-II RNA and control levels of MT-II protein ceased to grow. Hence, overexpression of MT-II provides a growth advantage in low folate.




This article has been cited by other articles:


Home page
CarcinogenesisHome page
J. W. Crott, S.-W. Choi, J. M. Ordovas, J. S. Ditelberg, and J. B. Mason
Effects of dietary folate and aging on gene expression in the colonic mucosa of rats: implications for carcinogenesis
Carcinogenesis, January 1, 2004; 25(1): 69 - 76.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1999 by the American Association for Cancer Research.